Panacea Pharmaceuticals Inc.
This article was originally published in Start Up
Executive SummaryPanacea Pharmaceuticals is developing products to detect and treat CNS diseases and cancer.
You may also be interested in...
A series of basic research insights around the cell death process called ferroptosis could form the underpinnings of a new class of treatments aimed at drug resistant tumors.
Recent clinical data using antisense drugs in neurological diseases are encouraging signs that targeting genetic drivers of ALS with antisense oligonucleotides or other gene-altering drugs could halt progression of several forms of the disease.